Efficacy and safety of booster vaccination against SARS-CoV-2 in dialysis and renal transplant patients: systematic review and meta-analysis.

Int Urol Nephrol · 2023 · PMC9890430 · PMID 36723829

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The literature suggests lower seroconversion rates after vaccination against SARS-CoV-2 in both dialysis and KTR patients than that for the healthy controls (27%, 88% and 100%, respectively), with a highly significant difference between the RRT methods [ 64 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.